26 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35470551 | Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study. | 2022 May | 6 |
2 | 30882962 | Modulatory effects of cannabinoids on brain neurotransmission. | 2019 Aug | 1 |
3 | 29063964 | Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology. | 2018 Feb | 2 |
4 | 27639448 | Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks. | 2017 May | 1 |
5 | 26123153 | Roles for the endocannabinoid system in ethanol-motivated behavior. | 2016 Feb 4 | 2 |
6 | 25510937 | Hippocampal cannabinoid transmission modulates dopamine neuron activity: impact on rewarding memory formation and social interaction. | 2015 May | 1 |
7 | 25859226 | Role of the endogenous cannabinoid system in nicotine addiction: novel insights. | 2015 | 1 |
8 | 24334069 | Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta. | 2014 Apr | 1 |
9 | 24495779 | Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes. | 2014 Jul 3 | 1 |
10 | 25014618 | Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population. | 2014 Oct | 3 |
11 | 25090972 | Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway. | 2014 Nov | 2 |
12 | 22391102 | The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently. | 2013 Mar | 1 |
13 | 23422373 | CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia. | 2013 Apr | 1 |
14 | 22265889 | Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output. | 2012 Jul 2 | 1 |
15 | 22306525 | Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism. | 2012 Jun | 2 |
16 | 22421165 | The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015. | 2012 Apr 10 | 1 |
17 | 22692568 | Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems. | 2012 Oct | 4 |
18 | 19367507 | Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders. | 2009 Apr | 2 |
19 | 18213623 | Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. | 2008 Dec 5 | 1 |
20 | 16762556 | Protective activation of the endocannabinoid system during ischemia in dopamine neurons. | 2006 Oct | 1 |
21 | 15878779 | Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. | 2005 Jun | 2 |
22 | 14993102 | Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. | 2004 Apr | 1 |
23 | 15125311 | [Role of endogenous cannabinoids in cerebral reward mechanisms]. | 2004 Mar | 1 |
24 | 14623357 | The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. | 2003 Nov 7 | 1 |
25 | 11803524 | Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. | 2001 Dec 8 | 1 |
26 | 11138722 | Role of cannabinoid receptor in the brain as it relates to drug reward. | 2000 Nov | 1 |